Use of atazanavir for improving the pharmacokinetics of drugs metabolized by UGT1A1

Details for Australian Patent Application No. 2005311672 (hide)

International Classifications

Event Publications

14 June 2007 PCT application entered the National Phase

PCT publication WO2006/060731 Priority application(s): WO2006/060731

28 January 2010 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp.

22 July 2010 Application Accepted

Published as AU-B-2005311672

18 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.